↓ Skip to main content

GSK-3 and mitochondria in cancer cells

Overview of attention for article published in Frontiers in oncology, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
GSK-3 and mitochondria in cancer cells
Published in
Frontiers in oncology, January 2013
DOI 10.3389/fonc.2013.00016
Pubmed ID
Authors

Federica Chiara, Andrea Rasola

Abstract

GSK-3 is a multifunctional kinase that is located in the cytosol, nucleus, and mitochondria of all cell types, and it is involved in the pathogenesis of a variety of diseases. In cancer, GSK-3 modulates the response of the cell death machinery to stress stimuli, including chemotherapeutics. Mitochondria are at the heart of the integration between survival and noxious signals; therefore, modulation of the mitochondrial functions carried out by GSK-3 is profoundly involved in the apoptosis escape capabilities that hallmark neoplasms. This review briefly covers the mechanistic interactions among oncogenic kinase pathways, GSK-3 activity and subsequent modulation of mitochondrial functions that shape the pro-survival phenotype of cancer cells, such as control of redox homeostasis and inhibition of the mitochondrial permeability transition pore.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Mexico 1 1%
Russia 1 1%
Spain 1 1%
Japan 1 1%
Unknown 62 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 18%
Student > Ph. D. Student 9 13%
Student > Master 9 13%
Professor > Associate Professor 6 9%
Student > Doctoral Student 5 7%
Other 12 18%
Unknown 14 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 31%
Biochemistry, Genetics and Molecular Biology 11 16%
Medicine and Dentistry 10 15%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Neuroscience 2 3%
Other 5 7%
Unknown 16 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2013.
All research outputs
#23,269,088
of 25,932,719 outputs
Outputs from Frontiers in oncology
#16,293
of 22,839 outputs
Outputs of similar age
#261,359
of 291,797 outputs
Outputs of similar age from Frontiers in oncology
#194
of 327 outputs
Altmetric has tracked 25,932,719 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,839 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,797 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 327 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.